What's Going On With Teladoc Health Stock Wednesday?

Teladoc Health Inc TDOC shares are trading lower Wednesday following mixed quarterly results from the telehealth company. Here's a look at the key metrics from the quarter.

• Q3 Revenue: $660.24 million missed estimates of $664.11 million
• Q3 EPS: 35 cent loss beat estimates for 37 cent loss

Access fees revenue increased 8% year-over-year, while other revenue grew 10%. U.S. revenue was up 7% and International revenue jumped 17%. Teladoc's Integrated Care segment saw revenue climb 9%. The BetterHelp segment was up 8% year-over-year. Total visits decreased 4% to 4.4 million versus 4.6 million in the prior year.

"As we look into 2024, we will continue to advance virtual care in ways large and small ... We will accelerate our efforts to drive value through improved business performance across the enterprise, undertaking a comprehensive operational review of the business to further improve our efficiency," said Jason Gorevic, CEO of Teladoc Health.

Guidance: Teladoc expects fourth-quarter revenue to be between $658 million and $683 million versus estimates of $686.56 million. Full-year revenue is expected to be between $2.6 billion and $2.625 billion versus estimates of $2.63 billion.

Teladoc anticipates a net loss of 23 to 33 cents per share in the fourth quarter and a full-year net loss of $1.40 to $1.50 per share. 

Check This Out: T-Mobile Boasts 850K New Postpaid Mobile Customers in Q3, Adjusted Free Cash Flow Soars 94% YoY

TDOC Price Action: Teladoc shares were down 6.18% at $17.01 at the time of writing, according to Benzinga Pro.

Photo: courtesy of Teladoc.